|
141
|
|
|
Mediator complex subunit 12L |
NIZIDS, NOPAR, TNRC11L, TRALP, TRALPUSH |
Alzheimer disease, Nonsyndromic intellectual disability, Platelet-type bleeding disorder, Developmental disability, Digestive system disease, Diverticular disease, Insomnia, Intellectual developmental disorder, Irritable bowel syndrome, Neurodevelopmental disorders, Non-specific syndromic intellectual disability, Parkinson disease |
|
142
|
|
|
MSS51 mitochondrial translational activator |
ZMYND17 |
|
|
143
|
|
|
Matrix metallopeptidase 21 |
HTX7, MMP-21 |
|
|
144
|
|
|
Mitochondrial methionyl-tRNA formyltransferase |
COXPD15, FMT1, MC1DN27 |
|
|
145
|
|
|
Methyltransferase 23, arginine |
C17orf95, MRT44 |
|
|
146
|
|
|
Musashi RNA binding protein 2 |
MSI2H |
Androgenetic alopecia, Cannabis abuse, Clonal hematopoiesis, Color vision deficiency, Keratitis, Ovarian epithelial cancer, Metabolic syndrome, Open angle glaucoma, Ovarian cancer, Schizophrenia, Diabetes mellitus, type 2 |
|
147
|
|
|
Mitochondrial contact site and cristae organizing system subunit 13 |
C19orf70, MIC12, MIC13, P117, QIL1 |
|
|
148
|
|
|
Methyl-CpG binding domain protein 3 like 2 |
- |
|
|
149
|
|
|
MIR1-1 host gene |
C20orf166, MIR133A2HG |
|
|
150
|
|
|
Microtubule interacting and trafficking domain containing 1 |
- |
|